Background Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a novel
autoimmune disease of central nervous system (CNS). It is unclear whether Epstein–Barr …

A diverse number of DNA and RNA viruses have the potential to invade the central nervous
system (CNS), causing inflammation and injury to cells that have a limited capacity for repair …

A number of studies have suggested that human herpesvirus 6A (HHV-6A) may play a role
in multiple sclerosis (MS). Three possible hypotheses have been investigated:(1) U24 from …

We recently reported that multiple sclerosis (MS) plasma contains IgG aggregates and
induces complement-dependent neuronal cytotoxicity (Zhou et al., 2023). Using ELISA, we …

Multiple sclerosis (MS) is a debilitating disease that arises from immune system attacks to
the protective myelin sheath that covers nerve fibers and ensures optimal communication …

There have been tremendous advances in the neuroimmunology of multiple sclerosis over
the past five decades, which have led to improved diagnosis and therapy in the clinic …

Abnormal inflammatory states in the brain are associated with a variety of brain diseases.
The dynamic changes in the number and function of immune cells in cerebrospinal fluid …

Background and Objective: Prior Epstein–Barr virus (EBV) infection is associated with an
increased risk of pediatric-onset multiple sclerosis (POMS) and adult-onset multiple …

Background and Objectives The role of B cells in the pathogenic events leading to relapsing
multiple sclerosis (R-MS) has only been recently elucidated. A pivotal step in defining this …

Introduction Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central
nervous system (CNS). Ursolic acid (UA) can be used in the MS treatment with anti …